Jam

Adicet Bio, Inc. announced an inducement award to a new employee joining in September 2025. The individual received a non-qualified stock option to purchase 9,800 shares at $0.81 per share, the closing price on the grant date. The options vest over four years with a one-year cliff, contingent upon continued employment. The award was granted under the 2022 Inducement Plan and approved by the independent compensation committee, adhering to Nasdaq Listing Rule 5635(c)(4). Adicet Bio focuses on allogeneic gamma delta T cell therapies for autoimmune diseases and cancer.

Exiger, an AI-powered supply chain intelligence platform, was recognized as a Value Leader in Spend Matters™ Fall 2025 SolutionMap for the third consecutive time. Exiger received the highest functional scores in Third-Party Risk Management (TPRM) and Supply Chain Risk Management (SCRM). The SolutionMap assessment included 115 vendors and combines RFIs, technical assessments, and customer ratings. This recognition follows Exiger’s other recent achievements, including being named a Leader in Gartner® and Omdia reports. Exiger’s platform provides visibility, proactive risk surfacing, and automated compliance in supply chains.

bioAffinity Technologies announced the completion of a public offering, generating $4.8 million in gross proceeds. The offering included shares of common stock and pre-funded warrants. WallachBeth Capital, LLC served as the placement agent. bioAffinity focuses on non-invasive cancer diagnostics, including CyPath® Lung, a Laboratory Developed Test for early lung cancer detection. The company addresses the growing precision diagnostics market with a focus on improving patient outcomes through early diagnosis. The announcement contains forward-looking statements subject to risks detailed in SEC filings.

BetterInvesting Magazine will feature Vertiv Holdings Co. as its “Stock to Study” in December 2025, providing investors with an in-depth analysis of the company’s fundamentals, including sales trends, earnings, profit margins, and ROE. The report aims to offer a comprehensive understanding of Vertiv’s financial health and market position within the growing digital infrastructure sector. The same issue will also include a fundamental review of CVS Health Corp. BetterInvesting is a non-profit dedicated to investment education.

SharkNinja, in partnership with MassChallenge, is launching the SharkNinja Innovation Challenge to support STEM innovators and early-career entrepreneurs. The nationwide competition invites university students and young individuals (18-24) to submit applications by October 24th in categories like consumer problem-solving, sustainability, and universal design. Finalists will receive mentorship, resources for prototyping, and IP counsel. Winners will get cash prizes and mentorship to accelerate growth, with a live pitch finale in early 2026. This initiative falls under SharkNinja’s “Innovation for Impact” program.

Target is partnering with Netflix for a “Stranger Things” retail experience, launching over 150 themed items in October. Target aims to be the ultimate destination for fans of the show’s final season with a dedicated in-store and online shopping space, immersive experiences, and a nostalgia-driven marketing campaign. The collection includes exclusive items from Funko, Mattel and others. Target is also creating a 1987-themed store to bring the fictional world of Hawkins, Indiana to life.

Upstream Bio (UPB) presented data at the European Respiratory Society Congress showcasing verekitug’s mechanism of action. Verekitug prevents TSLP binding by occupying receptor sites and outcompetes TSLP even with preformed receptor complexes. This supports its potential for treating TSLP-driven respiratory diseases. Phase 2 data in CRSwNP showed significant improvements. A Phase 2 readout in severe asthma is expected in Q1 2026. Verekitug’s high affinity and inhibition of the TSLP receptor could lead to less frequent dosing than current therapies.

Ericsson will publish its Q3 2025 financial results on October 14, 2025, at approximately 7:00 AM CEST. The report will be available on the investor relations website. A live webcast hosted by CEO Börje Ekholm and CFO Lars Sandström will follow at 9:00 AM CEST to discuss the results and address questions. Investors and analysts will focus on Ericsson’s 5G market share, supply chain impact, new revenue streams, and cost-cutting initiatives in the context of the evolving telecommunications landscape. The webcast will be available on-demand.

Primerica’s Household Budget Index™ (HBI™) indicates increasing financial strain on middle-income families. The August reading shows a 0.1% monthly and 0.8% yearly rise, reflecting a 3.3% inflation rate tailored to middle-income spending, exceeding the overall CPI. Rising costs of essential goods (food, utilities, gasoline, insurance, healthcare) are outpacing wage growth, disproportionately affecting this demographic. Primerica emphasizes the HBI™’s importance for informed policymaking to address the economic challenges faced by over 55% of the U.S. population. The HBI™ utilizes data from various government sources.

Edgewater Wireless (TSXV: YFI, OTC: KPIFF) reported Q1 FY2026 results, highlighting progress in Spectrum Slicing™ technology and securing $921,000 in non-dilutive funding. Key achievements include showcasing Spectrum Slicing, completing RF front-end packaging, and prototyping an AI subsystem. The company extended the maturity of convertible debentures to 2027 for enhanced financial flexibility. A net loss of $359,956 was reported with a working capital deficiency. Focus remains on commercializing Spectrum Slicing through silicon/IP licensing and securing partnerships, while addressing challenges in a competitive market.